FundedIQ
Biotechnology

iQure Pharma: Funding, Investors & Team (Oct 2026)

iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that specializes in creating innovative treatments on a global scale.

www.iqurepharma.com LinkedIn Wilmington, United States 1-10 employees
Biotechnology Pharmaceutical Therapeutics
Total raised
$1.7M
Rounds
3
Latest
Undisclosed round
Jun 2026

iQure Pharma has raised $1.7M across 3 funding rounds on record, the most recent an undisclosed round announced in Jun 2026.

iQure Pharma Company Profile and Key Stats

Total funding raised
$1.7M
across 3 rounds on record
Funding rounds on record
3
1 with no disclosed amount
Latest funding round
Undisclosed round
Jun 2026
Employees
1-10
reported band
Headquarters
Wilmington, United States

Latest funding round on record: Jun 2026.

iQure Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed round
$1.5M
Undisclosed round
$220k

1 of 3 rounds was announced without a disclosed amount and is excluded from the total.

iQure Pharma raised $220k in an undisclosed round announced in Apr 2024.

1.6 years later, an undisclosed round of $1.5M was announced in Nov 2025.

7 months later, an undisclosed round was announced in Jun 2026 with no disclosed amount.

iQure Pharma Founders and Leadership Team

Name
Role
Contact
Henk De Wilde
Founder
—
Peter Schiemann
Founder
Locked
Pawel Zolnierczyk
—
Locked

Contact details for the iQure Pharma team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

iQure Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Funded Startups Like iQure Pharma in Biotechnology and Wilmington

Companies Similar to iQure Pharma

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

iQure Pharma Funding FAQs

What does iQure Pharma do?

iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that specializes in creating innovative treatments on a global scale.

How much funding has iQure Pharma raised?

iQure Pharma has raised $1.7M across 3 rounds on record.

When did iQure Pharma last raise funding?

iQure Pharma's most recent funding round on record was announced in Jun 2026. The amount was not disclosed.

Who founded iQure Pharma?

FundedIQ lists Henk De Wilde (Founder), Peter Schiemann (Founder) at iQure Pharma.

Where is iQure Pharma headquartered?

iQure Pharma is based in Wilmington, Delaware, United States.

How many employees does iQure Pharma have?

iQure Pharma is in the 1-10 employee band.

About FundedIQ's iQure Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iQure Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.